agglomerate 发表于 2025-3-28 15:02:49
Genetics of Adrenocortical Cancers,ongly associated to patient outcome. Briefly, one subtype, of poor outcome, is characterized by a specific transcriptome and miRnome signature, a high number of chromosome alterations (noisy alterations), specific DNA methylation pattern (CpG islands methylator phenotype or CIM), and mutations in re忍耐 发表于 2025-3-28 22:44:10
http://reply.papertrans.cn/63/6225/622427/622427_42.pngGORGE 发表于 2025-3-28 23:25:27
http://reply.papertrans.cn/63/6225/622427/622427_43.pngCoeval 发表于 2025-3-29 06:24:01
http://reply.papertrans.cn/63/6225/622427/622427_44.pngProstaglandins 发表于 2025-3-29 08:16:02
Cushing Syndrome: Presentation, Diagnosis, and Treatment, Including Subclinical Cushing Syndrome,anently curing the disorder by resecting or ablating its cause to controlling the hypercortisolism in patients in whom a cure cannot be achieved. Surgical resection of the causal lesion(s) is generally the first-line approach. The choice of second-line treatments, including medications, irradiationobstinate 发表于 2025-3-29 13:52:03
Management of Pheochromocytoma and Paraganglioma,achieved with alpha and beta adrenoceptor blockade, calcium channel blockers, and inhibitors of catecholamine synthesis. Surgical resection represents the main form of curative treatment in patients with nonmetastatic disease. Optimization of the preoperative hemodynamic status is critical in prevencocoon 发表于 2025-3-29 16:40:12
http://reply.papertrans.cn/63/6225/622427/622427_47.png直觉好 发表于 2025-3-29 22:06:24
http://reply.papertrans.cn/63/6225/622427/622427_48.pnggain631 发表于 2025-3-30 03:30:15
http://reply.papertrans.cn/63/6225/622427/622427_49.pngchemoprevention 发表于 2025-3-30 06:32:19
http://reply.papertrans.cn/63/6225/622427/622427_50.png